Name: Cagrilintide
Brand: Shiguang (Hebei) Supply Chain Management Co.,Ltd.
Price: 100 USD
Rating: 4.8 (50 reviews)

Cagrilintide

Cagrilintide‌ is a long-acting amylin analogue that is primarily used in weight management. It helps with weight loss by mimicking the effects of amylin, reducing energy intake and regulating food choices and preferences. Cagrilintide has a half-life of about 7-8 days, which means it stays active in the body for a longer period of time, helping to maintain a stable effect ‌.

Where to buy

Specification of Cagrilintide

CAS No.	53-84-9	Molecular Weight	663.425
Molecular Formula	C21H27N7O14P2	Melting Point	140 - 142ºC

Product Clinical research

Cagrilintide has shown good safety and tolerability in clinical studies. In a Phase 1b clinical trial, Cagrilintide was used in combination with Semaglutide (GLP-1 analogue), which showed a significantly higher percentage of weight loss in participants than in the placebo group. Specifically, the Cagrilintide 1.2 mg and 2.4 mg groups had average weight loss percentages of -15.7% and -17.1%, respectively, compared with -9.8% in the placebo group.

Product Market prospect

The market for Cagrilintide is promising, especially in the field of obesity treatment. Novo Nordisk is studying CagriSema, its mixture with semaglutide, which is expected to help patients lose at least 25 percent of their body weight and may cause no more side effects than semaglutide alone. CagriSema is also exploring its potential as a treatment for type 2 diabetes.

Product Research and development background

Cagrilintide’s development background shows its potential in weight management. Novo Nordisk is actively advancing its clinical studies to demonstrate CagriSema’s superiority and maintain its leading position in the treatment of obesity.

Products